M. Ukkonen

发表

Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis

P. Dastidar, T. Lehtimäki, I. Elovaara, 1999, Journal of the Neurological Sciences.

Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study

P Dastidar, I. Elovaara, P. Dastidar, 2009, Multiple sclerosis.

Volumetric quantitation by MRI in primary progressive multiple sclerosis: volumes of plaques and atrophy correlated with neurological disability

I. Elovaara, P. Dastidar, T. Heinonen, 2003, European journal of neurology.

Cell surface adhesion molecules and cytokine profiles in primary progressive multiple sclerosis

I. Elovaara, P. Dastidar, Xingchen Wu, 2007, Multiple sclerosis.

Once‐weekly 22μg subcutaneous IFN‐β‐1a in secondary progressive MS: a 3‐year follow‐up study on brain MRI measurements and serum MMP‐9 levels

I. Elovaara, P. Dastidar, H. Huhtala, 2007 .

Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients

T. Tapiola, A. Remes, L. Luostarinen, 2021, Journal of Neurology.

Urodynamic findings in primary progressive multiple sclerosis are associated with increased volumes of plaques and atrophy in the central nervous system

T. Tammela, I. Elovaara, P. Dastidar, 2004, Acta neurologica Scandinavica.

Promoter polymorphism of IL‐10 and severity of multiple sclerosis

T. Lehtimäki, I. Elovaara, T. Koivula, 2003, Acta neurologica Scandinavica.

Plasminogen activator inhibitor 1 gene and risk of MS in women

T. Lehtimäki, I. Elovaara, T. Koivula, 2000, Neurology.

Increased disability and MRI lesions after discontinuation of IFN‐β‐1a in secondary progressive MS

I. Elovaara, P. Dastidar, H. Huhtala, 2005, Acta neurologica Scandinavica.

The combination of HLA-DR1 and HLA-DR53 protects against MS

T. Lehtimäki, I. Elovaara, T. Koivula, 2001, Neurology.

Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy.

T. Lehtimäki, I. Elovaara, P. Dastidar, 2000, Archives of neurology.

A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis

T. Lehtimäki, I. Elovaara, P. Laippala, 2001, Journal of the Neurological Sciences.

Increased nitric oxide products in CSF in primary progressive MS may reflect brain atrophy

I. Elovaara, J. Peltola, M. Ukkonen, 2001, Neurology.

Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes

I. Elovaara, M. Ukkonen, T. Jalonen, 2002, Journal of Neurology.